Trial Profile
A Phase I/II Trial of an Allogeneic Cell Based Vaccine [Onyvax-CR; Onyvax] and an Anti-Idiotypic Antibody Vaccine [anti-idiotype cancer vaccine 105AD7; Onyvax] Approach for Metastatic Adenocarcinoma of the Colon or Rectum
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 23 Nov 2015
Price :
$35
*
At a glance
- Drugs Anti-idiotype cancer vaccine 105AD7 (Primary) ; Alum; BCG; Colorectal cancer vaccine
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Onyvax
- 10 Sep 2005 New trial record.